Lack of effect of cefixime on the metabolism of vitamin K1.
It seems that cephalosporins bearing a N-methyl-thio-tetrazole or a methyl-thiadiazole moiety in their molecule can cause hypoprothombinemia in patients via inhibition of the metabolism of vitamin K1 if they are in addition in a vitamin K1-deficient state. The authors therefore studied the effects of two different oral doses (200 and 400 mg) of the cephalosporin cefixime on the metabolism of vitamin K1 in healthy volunteers, because the accumulation of vitamin K1-2,3-epoxide in plasma is a sensitive marker of coumarin-like activity of drugs. The results indicate that the development of hypoprothrombinemia due to an impairment of the metabolism of vitamin K1 by cefixime seems unlikely because only trace amounts of vitamin K1-2,3-epoxide could be determined in the plasma of the subjects investigated.
Department of Clinical Pharmacology, Rehabilitationszentrum, Bad Krozingen, FRG.
D
D
Trenk
F
F
Wagner
H
H
Bechtold
B
B
Nies
E
E
Jähnchen
D000284:Administration, Oral; D000328:Adult; D020682:Cefixime; D002439:Cefotaxime / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D011292:Premedication; D014812:Vitamin K / Q000037:antagonists & inhibitors / Q000097:blood / Q000378:metabolism*; D010837:Vitamin K 1 / Q000031:analogs & derivatives / Q000097:blood
D014812:Vitamin K; C016186:vitamin K1 oxide; D010837:Vitamin K 1; D020682:Cefixime; D002439:Cefotaxime